Press release
Breast Cancer Therapeutics Market 2020 Trends, Opportunity, Projection Analysis Forecast 2028
Breast Cancer Therapeutics Market Forecast 2021-2028
***Get Latest Updated Market Research Report with Free Sample Report
Market Overview:
The global breast cancer therapeutics market is set to gain impetus from the ongoing research and developments to come up with state-of-the-art drugs. This information is given by Fortune Business Insights™ in a new study, titled, “Breast Cancer Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy, and Immunotherapy), By Cancer Type (Hormone Receptor, and HER2+), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027.” The study further mentions that the market size was USD 21.58 billion in 2019 and is projected to reach USD 55.27 billion by 2027, exhibiting a CAGR of 13.1% during the forecast period.
COVID-19 Pandemic to Affect Growth Moderately as Cancer Requires Immediate Attention
The COVID-19 pandemic has moderately affected the growth of the breast cancer therapeutics industry worldwide as cancer is considered to be an essential condition that requires immediate medical attention. But, in some regions, there were a few postponements or cancellations of these procedures to prevent physical contact.
Request for Free Sample Report PDF @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/breast-cancer-therapeutics-
This Report Answers the Following Questions:
Which organizations are likely to generate the largest revenues?
What are the historical and predicted sizes of the global market?
Will the COVID-19 pandemic affect the market in the near future?
What are the strategies followed by companies to generate more sales?
Drivers & Restraints-
Increasing Development of State-of-the-art Products to Favor Growth
Nowadays, several renowned companies are constantly launching new breast cancer therapeutics worldwide. Most of these drugs are meant for the treatment of those types of breast cancers that were previously untreatable or the available drugs were not successful for providing positive outcomes. These factors are expected to accelerate the breast cancer therapeutics market growth in the forthcoming years. However, certain severe reactions can come up while undergoing this type of cancer therapeutics, such as targeted therapies. Patients can suffer from nausea, fatigues, rashes, gastrointestinal problems, or high blood pressure. These may hinder growth.
Segment-
Hormonal Therapy Segment to Register Lower Growth in Forthcoming Years
Based on therapy, the hormonal therapy segment generated 8.3% in terms of the breast cancer therapeutics market share in 2019. It is likely to exhibit lower growth in the coming years on account of the rising availability of their generic equivalents.
Regional Insights-
North America to Remain at the Forefront Stoked by Rising Awareness Programs
Regionally, North America procured USD 10.34 billion in 2019 in terms of revenue. The rising prevalence of breast cancer, presence of numerous providers of breast cancer therapeutics, and the surging awareness of this condition are expected to augment growth in this region. The American Cancer Society, for instance, declared that the U.S. is set to experience around 276,480 new cases of invasive breast cancer in 2020.
Europe, on the other hand, is likely to retain its second position fueled by the high demand for advanced and sophisticated breast cancer therapeutics. In Asia Pacific, the market would grow rapidly because of the increasing healthcare expenditure. Lastly, the Middle East & Africa and Latin America are anticipated to show robust growth on account of the rising patient population in both regions.
Competitive Landscape-
Key Players Aim to Gain Fast Track Approvals to Compete with Their Rivals
This global market houses a large number of companies that are nowadays striving to gain fast track approvals from government healthcare agencies to distribute and market their products. Some of the others are focusing on developing unique breast cancer therapeutics to cater to the unmet demand. Below are the two latest industry developments:
September 2020: Lupin introduced Lapatinib Tablets, 250 mg, after its partner Natco Pharma received approval from the USFDA. These will be used to treat patients suffering from metastatic or advanced breast cancer.
November 2019: Daiichi Sankyo Company and AstraZeneca declared that their HER2-directed antibody-drug conjugate named Enhertu was approved by the USFDA. It is meant for the treatment of adult patients living with metastatic or unresectable HER2-positive breast cancer.
Ask for Customization @ https://www.fortunebusinessinsights.com/enquiry/customization/breast-cancer-therapeutics-market-
COMPETITIVE LANDSCAPE
Product Launches by Major Companies to Strengthen their Market Position
The global nicotine replacement therapy market report observes that major companies such as GlaxoSmithKline plc and Johnson & Johnson Inc hold over 80% of the total share and are constantly focusing on consolidating their positions by introducing novel nicotine replacement therapy products in the global marketplace. Additionally, other players in the market are striving to strengthen their position by adopting strategies such as collaboration, merger and acquisition, and introduction of new products during the forecast period.
INDUSTRY DEVELOPMENT:
June 2020: Taat Herb Co., a flagship brand of Taat Lifestyles, announced the launch of its new hemp cigarettes from the Taat stable. According to the company, the new product dramatically replicates the exact experience of smoking a traditional cigarette and contains 50mg of canabidiol (CbeD) that is effective in reducing tobacco dependency.
A list of all the renowned therapeutics providers present in this global market:
Genentech (F. Hoffmann-La Roche Ltd) (South San Francisco, U.S.)
Eli Lilly and Company (Indianapolis, U.S.)
Novartis AG (Basel, Switzerland)
AstraZeneca (Cambridge, U.K.)
Pfizer Inc. (New York City, U.S.)
Sanofi (Paris, France)
Eisai Co. Ltd. (Tokyo, Japan)
Kyowa Kirin (Tokyo, Japan)
Bristol Myers Squibb (Celgene Corporation) (New York City, U.S.)
Merck & Co., Inc. (Kenilworth, U.S.)
Other Players
Speak To Analyst @ https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/breast-cancer-therapeutics
Table Of Content:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Breast Cancer, By Key Countries/Regions, 2019
Regulatory Scenario by Key Regions
Overview of Current Advances in R&D for Breast Cancer Therapeutics
Key Industry Developments
New Product Launches
Global Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis, Insights and Forecast – By Therapy
Targeted Therapy
Abemaciclib
Ado-Trastuzumab Emtansine
Everolimus
Trastuzumab
Ribociclib
Palbociclib
Pertuzumab
Olaparib
Others
Hormonal Therapy
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Chemotherapy
Immunotherapy
Market Analysis, Insights and Forecast – By Cancer Type
Hormone Receptor
HER+
Market Analysis, Insights and Forecast – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis, Insights and Forecast – By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
North America Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis – By Therapy
Targeted Therapy
Abemaciclib
Ado-Trastuzumab Emtansine
Everolimus
Trastuzumab
Ribociclib
Palbociclib
Pertuzumab
Olaparib
Others
Hormonal Therapy
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Chemotherapy
Immunotherapy
Market Analysis – By Cancer Type
Hormone Receptor
HER+
Market Analysis – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis – By Country
S.
Canada
Europe Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis – By Therapy
Targeted Therapy
Abemaciclib
Ado-Trastuzumab Emtansine
Everolimus
Trastuzumab
Ribociclib
Palbociclib
Pertuzumab
Olaparib
Others
Hormonal Therapy
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Chemotherapy
Immunotherapy
Market Analysis – By Cancer Type
Hormone Receptor
HER+
Market Analysis – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis – By Country/ Sub-Region
K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis – By Therapy
Targeted Therapy
Abemaciclib
Ado-Trastuzumab Emtansine
Everolimus
Trastuzumab
Ribociclib
Palbociclib
Pertuzumab
Olaparib
Others
Hormonal Therapy
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Chemotherapy
Immunotherapy
Market Analysis – By Cancer Type
Hormone Receptor
HER+
Market Analysis – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis – By Country/ Sub-Region
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis – By Therapy
Targeted Therapy
Abemaciclib
Ado-Trastuzumab Emtansine
Everolimus
Trastuzumab
Ribociclib
Palbociclib
Pertuzumab
Olaparib
Others
Hormonal Therapy
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Chemotherapy
Immunotherapy
Market Analysis – By Cancer Type
Hormone Receptor
HER+
Market Analysis – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis – By Country/ Sub-Region
Brazil
Mexico
Rest of Latin America
Middle East & Africa Breast Cancer Therapeutics Market Analysis, Insights and Forecast, 2016-2027
Key Findings / Summary
Market Analysis – By Therapy
Targeted Therapy
Abemaciclib
Ado-Trastuzumab Emtansine
Everolimus
Trastuzumab
Ribociclib
Palbociclib
Pertuzumab
Olaparib
Others
Hormonal Therapy
Selective Estrogen Receptor Modulators (SERMs)
Aromatase Inhibitors
Estrogen Receptor Downregulators (ERDs)
Chemotherapy
Immunotherapy
Market Analysis – By Cancer Type
Hormone Receptor
HER+
Market Analysis – By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Market Analysis – By Country/ Sub-Region
GCC Countries
South Africa
Rest of Middle East & Africa
Competitive Analysis
Global Market Share Analysis (2019)
Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
Genentech (F. Hoffmann-La Roche Ltd)
Eli Lilly and Company
Novartis AG
AstraZeneca
Pfizer Inc.
Sanofi
Eisai Co. Ltd.
Kyowa Kirin
Bristol Myers Squibb (Celgene Corporation)
Merck & Co., Inc.
Related Article @ https://marketresearchreportsfbi.wordpress.com/2021/10/21/nicotine-replacement-therapy-nrt-market-projection-by-top-key-players-glaxosmithkline-plc-johnson-johnson-inc-perrigo-company-plc-pierre-fabre-sa-laboratories-pfizer-inc-market/
NOTE: Our team is studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd
Twitter: https://twitter.com/FBInsightPvtLtd
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Breast Cancer Therapeutics Market 2020 Trends, Opportunity, Projection Analysis Forecast 2028 here
News-ID: 2445555 • Views: …
More Releases from Fortune Business Insights™
World Environment Day 2023: How Saving Water Can Help Us Save The Environment
Wastewater comes from homes, businesses, industrial sites and farms, as well as any stormwater or groundwater that enters the sewer system.
Specialised treatment plants process this wastewater. A combination of technologies is used to achieve the treatment objectives, based on the character of raw wastewater and use of the treated wastewater. These processes include primary, secondary and tertiary treatment. Our research, published today, found wastewater treatment removes a lot of particles,…
Cosmetics Market Research Analysis by Top Key Players, Types, New Trends and For …
The global cosmetics industry was valued at USD 277.67 billion in 2020 and is projected to grow from USD 287.94 billion in 2021 to USD 415.29 billion in 2028, exhibiting a CAGR of 5% during the 2021-2028 period.
In recent times, demand for makeup and skincare products has surged dramatically. Both men and women use it to enhance their overall appearance. The industry offers a wide variety of products, such as hair care, face care,…
Aquafeed Market Trends, Growth, Share, Size and Forecast Research Report 2028
The global aquafeed market size is anticipated to reach USD 85.17 billion by 2028 and exhibit a CAGR of 5.59% during the forecast period. The increasing popularity of aquafeed and the rising investments in the research and developments activities are projected to foster growth for the market. The market's growth is also ascribable to the increasing seafood trade due to the soaring seafood consumption and consumer expenditure on fish and…
Cricket Equipment Market Demand, Recent Trends, Size and Share Estimation by 202 …
The global cricket equipment market size was valued at USD 564.43 million in 2021 and USD 594.46 million in 2022. The market is expected to reach USD 897.02 million by 2029 with a CAGR of 6.05% during the forecast period. Growing demand for cricket bats and equipment from various institutions schools, colleges, cricket clubs, and fitness centers is anticipated to drive market growth. Increasing demand for customized sports products and cricket accessories…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
